scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Guy F Webster | |
P2860 | cites work | Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome | Q24655734 |
New treatments and therapeutic strategies for acne | Q33849718 | ||
Minocycline-induced lupus. A systematic review | Q33928009 | ||
The evolving role of Propionibacterium acnes in acne | Q34397443 | ||
Suicide, depression, and isotretinoin: is there a causal link? | Q34405234 | ||
Analysis of common side effects of isotretinoin | Q34405249 | ||
The integral role of topical and oral retinoids in the early treatment of acne | Q34529545 | ||
An overview of acne | Q39887861 | ||
Acne. A review of optimum treatment | Q40394342 | ||
Inflammation in acne vulgaris. | Q40452444 | ||
Bacterial resistance in acne. | Q52867258 | ||
Acne is not associated with abnormal plasma androgens. | Q52876617 | ||
Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris. | Q54137742 | ||
Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. | Q54196075 | ||
Propionibacterium acnes resistance to antibiotics in acne patients | Q54507910 | ||
First trimester topical tretinoin and congenital disorders | Q57945457 | ||
Acne and unemployment | Q70012194 | ||
Acne and rosacea | Q77401761 | ||
P433 | issue | 7362 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 5 | |
P304 | page(s) | 475-479 | |
P577 | publication date | 2002-08-01 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Acne vulgaris | |
P478 | volume | 325 |
Q40470153 | A novel enzyme with antioxidant capacity produced by the ubiquitous skin colonizer Propionibacterium acnes |
Q36557630 | Acne: more than skin deep |
Q43119546 | Acupoint Stimulation for Acne: A Systematic Review of Randomized Controlled Trials |
Q35814362 | Adapalene: a review of its use in the treatment of acne vulgaris |
Q89848720 | Antibacterial Activity Test of Extracts and Fractions of Cassava Leaves (Manihot esculenta Crantz) against Clinical Isolates of Staphylococcus epidermidis and Propionibacterium acnes Causing Acne |
Q38731769 | Bee Venom Inhibits Porphyromonas gingivalis Lipopolysaccharides-Induced Pro-Inflammatory Cytokines through Suppression of NF-κB and AP-1 Signaling Pathways. |
Q24202713 | Combined oral contraceptive pills for treatment of acne |
Q24240056 | Combined oral contraceptive pills for treatment of acne |
Q24246230 | Combined oral contraceptive pills for treatment of acne |
Q24186578 | Complementary therapies for acne vulgaris |
Q92277514 | Coprescription of Isotretinoin and Systemic Corticosteroids for Acne: An Analysis of the National Ambulatory Medical Care Survey |
Q35603426 | Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation |
Q90723578 | Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes |
Q90574528 | Evaluation of the effects of isotretinoin for treatment of acne on corneal sensitivity |
Q40985078 | Guillain-Barré syndrome seen in users of isotretinoin |
Q35843342 | Hedgehog signaling regulates sebaceous gland development |
Q52370959 | Highly sensitive detection and quantification of the secreted bacterial benevolence factor RoxP using a capacitive biosensor: A possible early detection system for oxidative skin diseases. |
Q28085629 | Human Microbiome: When a Friend Becomes an Enemy |
Q61455141 | Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens |
Q34999277 | In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. |
Q21263073 | Inducible Siphoviruses in superficial and deep tissue isolates of Propionibacterium acnes |
Q28071365 | Interventions to increase adherence to acne treatment |
Q33194327 | Laser treatment of acne |
Q24240669 | Light therapies for acne |
Q28246491 | New perspectives on antiacne plant drugs: contribution to modern therapeutics |
Q34632445 | Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives |
Q37720836 | PLIN2, the major perilipin regulated during sebocyte differentiation, controls sebaceous lipid accumulation in vitro and sebaceous gland size in vivo |
Q91994531 | Suppression of Propionibacterium acnes-Induced Skin Inflammation by Laurus nobilis Extract and Its Major Constituent Eucalyptol |
Q35952871 | The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth |
Q39027281 | The protective effects of melittin on Propionibacterium acnes-induced inflammatory responses in vitro and in vivo |
Q42873586 | The relationship of lipid profile and menstrual cycle with acne vulgaris |
Q24234299 | Tobacco smoking cessation for treating acne |
Q24240910 | Tobacco smoking cessation for treating acne |
Q35059633 | Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression |
Q24194287 | Topical benzoyl peroxide for acne |
Q90349608 | Topical benzoyl peroxide for acne |
Q26741233 | Treatment Modalities for Acne |
Search more.